UPNORTH INVESTMENT LTD purchased 10.3% of their position (200K shares) of TCR2 THERAPEUTICS INC. on the open market
Open‑market purchase worth $3.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/21/2019ACC: 0000899243-19-004398
10% Owner
Since Feb 2019
-9.86M
Net shares
Net seller
$3.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
2.14M acquired · 12M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+322.90K
Price / share
—
Trade value
—
% of position
New position
2/19/2019
0.00→322.90K
Common Stock
Indirect
Shares
+1.61M
Price / share
—
Trade value
—
% of position
500.0%
2/19/2019
322.90K→1.94M
Common Stock
Indirect
Shares
+200K
Price / share
$15.00
Trade value
$3M
% of position
10.3%
2/19/2019
1.94M→2.14M
Total
Net shares
+2.14M
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/19/2019 | C · Conversion | +322.90K | — | — | New position | 0.00 | 322.90K |
| Common Stock Indirect | 2/19/2019 | C · Conversion | +1.61M | — | — | 500.0% | 322.90K | 1.94M |
| Common Stock Indirect | 2/19/2019 | P · Purchase | +200K | $15.00 | $3M | 10.3% | 1.94M | 2.14M |
| Total | +2.14M | $3M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
322.90K shares
Shares
−2M
Strike price
Held after
0.00
Exercisable
—
2/19/2019
Series B Preferred Stock
Indirect
Converts to
Common Stock
1.61M shares
Shares
−10M
Strike price
Held after
0.00
Exercisable
—
2/19/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock322.90K shares | 2/19/2019 | C · Conversion | −2M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.61M shares | 2/19/2019 | C · Conversion | −10M | — | 0.00 |